SCHEMBL3125828

SCHEMBL3125828

CCCCOc1cc(CN2CCC(n3c(=O)[nH]c4cc(OC(=O)O)ccc43)CC2)ccc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 10/20 0.52
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PMP22 Q01453 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
DRD2 P14416 3/20 0.45
DRD3 P35462 3/20 0.45
DRD4 P21917 2/20 0.45
CHRM1 P11229 1/20 0.45
OPRK1 P41145 2/20 0.44
OPRD1 P41143 1/20 0.44
OPRL1 P41146 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
HTR2A P28223 1/20 0.44
SLC6A4 P31645 1/20 0.44
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3141595 0.97 OPRM1 (0.52) OPRM1BCHEACHEDRD2DRD3
SCHEMBL3138400 0.94 OPRM1 (0.54) OPRM1KDM4EALDH1A1NPSR1DRD2
SCHEMBL3133946 0.93 OPRM1 (0.51) OPRM1BCHEACHEDRD2DRD3
SCHEMBL3142452 0.90 OPRM1 (0.51) OPRM1NPSR1DRD2DRD3DRD4
SCHEMBL3089968 0.90 OPRM1 (0.51) OPRM1KDM4EALDH1A1PMP22NPSR1
SCHEMBL3124946 0.89 OPRM1 (0.52) OPRM1ALDH1A1BCHEACHEDRD2
SCHEMBL3134424 0.88 OPRM1 (0.53) OPRM1DRD2DRD3DRD4CHRM1
SCHEMBL3137562 0.86 OPRM1 (0.48) OPRM1ALDH1A1BCHEACHEDRD2
SCHEMBL3085149 0.85 AKT1 (0.49) OPRM1DRD2DRD3DRD4CHRM1
SCHEMBL3125864 0.85 OPRM1 (0.47) OPRM1ALDH1A1BCHEACHEDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2142528-B1 1-(1-BENZYLPIPERIDIN-4-YL)BENZIMIDAZ0LE -5-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS HOFFMANN LA ROCHE (CH) 2010-07-07 EP claimed